期刊文献+

羟苯磺酸钙胶囊联合复方丹参滴丸治疗糖尿病性视网膜病及肾病的疗效 被引量:23

Effects of calcium dobesilate capsule combining compound dansen dropping pill in the treatment of diabetic retinopathy and diabetic nephyopathy
下载PDF
导出
摘要 目的观察羟苯磺酸钙胶囊联合复方丹参滴丸治疗糖尿病性视网膜病变及肾病的疗效。方法将65例2型糖尿病并发糖尿病性视网膜病及肾病患者随机分为2组,对照组(口服复方丹参滴丸每次270mg,tid);治疗组(口服复方丹参滴丸每次270mg+羟苯磺酸钙胶囊每次500mg,tid),均连服3个月;观察2组患者治疗前后眼底的变化、血流变、血肌酐、尿素氮及24h尿蛋白定量的变化。结果眼底病变的改善,治疗组比对照组明显增多,恶化者明显减少(P<0.01);治疗组降低血液粘稠度的疗效更加明显;联合治疗更能减少尿蛋白的排出、降低血肌酐与尿素氮水平,减轻肾损害,保护肾功能。结论复方丹参滴丸联合羟苯磺酸钙胶囊治疗糖尿病性视网膜病及肾病疗效优于单用复方丹参滴丸治疗。 Objective To evaluate the effect of calcium dobesilate capsule combining compound dansen dropping pill treating diabetic retinopathy and diabetic nephyopathy. Methods Sixty-five patients with diabetic retinopathy and diabetic nephyopathy were randomlied into two groups, control group ( compound dansen dropping pill po 500 mg, tid, n = 32) ; trial group ( compound dansen dropping pill po 500 mg + calcium dobesilate po 270 mg,tid, n = 33 ) for three months. The change of eye ground,blood rheology, serum creatinine, urea nitrogen,24 hours urine protein were Observe. Results Trial group were obviously muh than control group about eye ground improved, ang aggravated obviously reduced. (P 〈 0.01 ). Trial group degrade blood rheology and urine protein, discharge degrade serum creatinine and urea nitrogen, to lessen kidney damage, protection kidney were more obviously than control group. Conclusion The effect of treating diabetic retinopathy and diabetic nephyopathy by combining calcium dobesilate pill and compound dansen dropping pill were good than take compound dansen dropping pill alone.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2009年第4期294-297,共4页 The Chinese Journal of Clinical Pharmacology
关键词 羟苯磺酸钙胶囊 复方丹参滴丸 糖尿病视网膜病变 糖尿病肾病 calcium dobesilate capsule compound dansen dropping pill diabetic retinopathy diabetic nephyopathy
  • 相关文献

参考文献8

  • 1Tejerina T, Ruiz E. Calcium dobesilate:pharmacology and future approaches [ J ]. Gen Pharmacol, 1998 ;31:357 - 360.
  • 2李治平,许迅,黄宇峰,朱剑锋,王晓珏,胡宏慧,何志平.体外孵育的非酶糖基化终产物诱导正常大鼠类糖尿病性视网膜血管病变研究[J].中华眼科杂志,2003,39(6):352-356. 被引量:21
  • 3方勤.糖尿病肾病发病机制的研究进展[J].中国实用内科杂志,1999,19(4):239-240. 被引量:104
  • 4Hannaert P, Brunet J, Farine JC, et al. Antioxidant - angioprotective actions of calcium dobesilate in diabetic rats [ J ]. Int J Angiol, 1999 ;8 : 16 - 20.
  • 5Brunet L, Farine JV, Garay RP, et al. Angioprotective action of calcium dobesilate against reactive oxygen species - induced capillary permeability in the rat [ J ]. Eur J Pharmacol, 1998 ; 358 : 213 - 220.
  • 6Ruiz E, Tejerina T. Calcium dobesilate increases endothelium -dependent relaxation in endothelium - injured rabbit aorta [ J ]. Pharmacol Res, 1998 ;38:361 - 366.
  • 7Suschek C, Kolb - Bachofen V. Dobesilate enhances endothelial nitric oxide synthase - activity in macro - and micrivascular endothelial cells [ J ]. Br J Pharmacol, 1997 ; 122 : 1502 - 1508.
  • 8杨金奎,赵秀丽,狄福松,何戎华,王亚东,王竹兰,王理理,田成功,王新娥.羟苯磺酸钙胶囊治疗2型糖尿病肾病和视网膜病变[J].中国临床药理学杂志,2002,18(5):323-327. 被引量:24

二级参考文献5

  • 1刘慧霞,韩秀云.导升明治疗糖尿病肾病的临床观察[J].湖南医科大学学报,1994,19(5):423-425. 被引量:5
  • 2罗佐杰.导升明降低糖尿病肾病微量白蛋白尿的临床研究[J].中华内分泌代谢杂志,1996,12:183-185.
  • 3杨永年 朱禧星 等.糖尿病慢性并发症.现代糖尿病学[M].上海:上海医科大学出版社,2000.299-370.
  • 4王竞 张水湛 等.导升明治疗单纯性糖尿病视网膜病变的临床研究[J].中华眼底病杂志,1995,11:224-226.
  • 5张惠蓉.消化铺片技术[A].见:张惠蓉主编.眼循环及其相关疾病[C].北京:北京医科大学,中国协和医科大学联合出版社,1993.19.

共引文献146

同被引文献195

引证文献23

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部